Abstract

Since the quality assurance system mentioned in the guideline for good clinical practice (GCP) for trials on medicinal products in the European Community is all too often limited to the data verification by clinical research monitors, the requirement to establish a quality system is placed in a broader perspective and extended to all data management activities. To implement a full quality system, commitment by management is required. Quality control/quality assurance (QC/QA) can only be effective in data management if the resources are provided to in-process personnel to perform validations through in-process quality control and to the independent QA audit group responsible for in- and post-study auditing.

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.